Growing evidence suggests that excess glucocorticoids (GCs) exposure during the pregnancy results in behavioral abnormality in offspring. Although research using animal models has demonstrated that systemic GCs treatment impairs development of fetal brain, direct impact of GCs on the phenotype of embryonic neural stem/progenitor cells (eNSPCs) and its mechanism has not been fully understood. Here, we investigated the effect of chronic GCs exposure on cell proliferation, differentiation, and survival of eNSPCs in vitro. Corticosterone (CORT, a murine GC) treatment did not affect the proliferation of eNSPCs. On the other hand, decreased expression of neuronal, synaptic, and astroglial marker proteins were observed when the differentiation of eNSPCs was induced in the presence of CORT. CORT also reduced the survival rate of eNSPCs after the differentiation. Moreover, CORT inhibited extracellular signal-regulated kinase (ERK) and phosphatidylinositol 3-kinase/Akt (PI3K/Akt) signaling pathways, which were activated during cell differentiation of eNSPCs. Inhibiting these signaling pathways reduced neural differentiation and eNSPCs viability, indicating their essential roles in the eNSPCs differentiation. Furthermore, IGF-I, a potent PI3K/Akt and ERK signaling stimulator, partially restored the adverse effect of CORT on eNSPCs, suggesting a possible involvement of the repression of these intracellular signaling in the GCs-caused eNSPCs impairment.
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Introduction
Growing clinical evidence shows that maternal stress during pregnancy is associated with the abnormality of behavioral and emotional development in children and the increased risk of psychiatric diseases including attention deficient hyperactivity disorder, depression, schizophrenia, and autism (Graignic-Philippe et al., 2014) . In animal studies, it has been demonstrated that prenatal stress causes reduced exploration activity, decreased spatial memory, inability to extinguish conditioned fear memory, increased anxiety, and depression-like behavior (Alonso et al., 1991; Bingham et al., 2013; Lordi et al., 2000; Salomon et al., 2011; Schneider et al., 2002) . Although the underling mechanism of adverse influence of prenatal stress is not completely understood, it has been proposed that excess glucocorticoids (GCs) exposure is involved in the negative effect of prenatal stress on the central nervous system (CNS) function (Salomon et al., 2011; Wilcoxon and Redei, 2007) . GCs are secreted from the adrenal gland in response to the stressful conditions, and trigger coping response via activating glucocorticoid receptor (GR) (De Kloet et al., 1998) . Normally, fetal GCs levels is retained lower than that of maternal plasma by placental 11 beta-hydroxysteroid dehydrogenase type 2 (11␤-HSD2) http://dx.doi.org/10.1016/j.neures.2016.07.002 0168-0102/© 2016 Elsevier Ireland Ltd and Japan Neuroscience Society. All rights reserved.
